This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Jan. 30, 2014

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Get up to date information on nutrition and nutrition research from Michael Greger, M.D. at NutritionFacts.org. Click here to view the website!

Granix is now available in the fight against neutropenia during chemotherapy. Click here to view the USPI! Visit www.granixrx.com for more information.

Click here to view the following free CME/CEU program:
Non-Invasive Pre Natal Testing: What Managed Care Needs to Know

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

On Aug 19, 2013, the FDA issued a label change for ADCETRIS® (brentuximab vedotin). Below is a copy of the updated USPI for your review. Key label changes found within the attachments include:

1. Dosage and Administration Section 1: 16 cycle limitation has been removed from the label. New label states "Continue treatment until disease progression or unacceptable toxicity"

2. Warnings and Precautions Section 5: Growth factor support added for consistency with Dose Modification in section 2.2


CLICK HERE to view the USPI.

The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Click here to view the white paper.


 




GENOMICS

Study: Jet lag, late nights and naps disrupt gene function
Forbes
Business travelers, shift workers, college students and overworked tech workers, beware. Unusual sleep patterns, particularly sleeping during the day and staying up late at night, wreak havoc with the activity of your genes, new research shows. Researchers at the Sleep Research Center at the University of Surrey in the U.K. interrupted study participants' sleep at regular intervals over three days, taking blood samples to monitor gene function.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




DNA study: Light skin genes evolved more recently than previously thought
The Huffington Post
An ancient European hunter-gatherer man had dark skin and blue eyes, a new genetic analysis has revealed. The analysis of the man, who lived in modern-day Spain only about 7,000 years ago, shows light-skin genes in Europeans evolved much more recently than previously thought.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


De novo gene mutations linked to schizophrenia
Medscape
De novo genetic mutations in individuals with schizophrenia cluster in specific proteins that play a key role in brain function and overlap with mutations seen in autism, an international team of scientists report. Although inherited genetic mutations account for most of the genetic risk for schizophrenia, emerging evidence shows that uninherited (de novo) mutations also are involved.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CEUS: RN, CCM, Safety Training

Get CEUs and Safety Training for your Nurses and Case Managers! Group rates available! CareerSmart offers online CEUs and safety training applicable for Nurses, Case Managers and other healthcare professionals. They are designed to help staff prevent work-related injuries and maintain compliance with mandated continuing education requirements.
 


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Sony forms genome analysis company in move towards personalized medicine
The Verge
Sony is forming a new company to focus on genome research with a view towards realizing personalized medicine and healthcare. The venture, currently called P5 Inc., is a collaboration with M3, a medical company in which Sony is the majority stakeholder, and Illumina, a U.S.-based manufacturer of genome-sequencing equipment. News of the tie-up between Sony and Illumina, which will be a minority investor, was first reported by Jiji Press last year.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Personalized medicine slogs toward reality
Discover Magazine
For years, medical researchers have been talking about the day when babies will have their whole genomes sequenced at birth, the day when genomic analysis will allow every patient to be treated not just based on her condition but on which treatment is the best match for her genetic quirks. There will be a day, they say, when we will all carry our genomes around on a thumb drive. But the hurdles, fiscal and otherwise, have proven difficult to overcome.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


REGENERATIVE MEDICINE


Scientists make pure precursor liver and pancreas cells from stem cells
Medical News Today
A new study published in the journal Cell Stem Cell, describes how scientists have developed a way of producing highly sought populations of a pure tissue-specific cell from human pluripotent stem cells. Human pluripotent stem cells are precursor cells than can produce over 200 distinct cell types in the human body.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study says new method could be a quicker source of stem cells
The New York Times
A surprising study has found that a simple acid bath might turn cells in the body into stem cells that could one day be used for tissue repair and other medical treatments. The technique, performed only with cells from mice, might turn out to be a quicker and easier source of multipurpose stem cells than methods now in use.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


EMERGING MEDICAL TECHNOLOGIES


Google Glass now framed for prescriptions
CNET
The top-requested Google Glass improvement is now a reality, as Google unveils its plan for prescription Google Glass frames. Available at the Google Glass website, prescription frames for the Internet-enabled headset cost $225, in addition to the $1,500 entry fee to the Explorer program. Google is adding four titanium frame styles — Bold, Curve, Thin, and Split — and two new tinted shade styles &mdahs; Classic and Edge — to the mix.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Apple hires medical tech experts to work on iWatch
ITProPortal
Apple has hired two experts in the medical tech field in order to ramp up its wearable technology plans that would include a patch to measure blood as well as biosensors. 9to5Mac reports that Nancy Dougherty from startup Sano Intelligence and Ravi Narasimhan of Vital Connect have joined to work with the team that is putting together the hardware behind the long anticipated iWatch.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
Study: Jet lag, late nights and naps disrupt gene function
Forbes
Business travelers, shift workers, college students and overworked tech workers, beware. Unusual sleep patterns, particularly sleeping during the day and staying up late at night, wreak havoc with the activity of your genes, new research shows.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Searching genes to avoid medical side effects
The Wall Street Journal
Scientists searching for a way to avoid prescribing medications to patients that may cause dangerous physical or behavioral responses are turning increasingly to those patients' DNA.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Sleep during the day may throw genes into disarray
HealthDay News via WebMD
Sleeping during the day — a necessity for jet-lagged travelers and those who work overnight shifts — disrupts the rhythms of about one-third of your genes, a new study suggests.

Share on FacebookTwitterShare on LinkedinE-mail article
read more




MANAGED HEALTHCARE NEWS


Stage 2 meaningful use readiness a growing concern
By Pamela Lewis Dolan
A survey recently released by the Centers for Disease Control and Prevention found there has been tremendous growth in electronic health record use in the U.S. over the past several years, thanks in part to the meaningful use incentive program. But there may be a speed bump in the road to a connected healthcare system as the meaningful use program enters its second stage. The survey found the number of office-based physicians with some type of EHR system grew from 18 percent in 2001 to 78 percent in 2013. But just 13 percent had systems capable of meeting at least 14 of the 17 core objectives required for Stage 2 of the three-stage program.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Know the health insurance deadline? Most don't
The Atlantic
In a survey out this morning, only 45 percent of Americans correctly identified March 31 as the deadline to purchase health insurance as required under the Affordable Care Act. The rate of correct responses was lowest among the 18 to 29 age group, those who make less than $30,000, and those without college degrees. Sixty-two percent said they assumed that the deadline would be pushed back.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


The impact of FDA's social media guidance for pharmaceutical companies
By Pamela Lewis Dolan
The Food and Drug Administration took a significant step forward in clarifying the responsibilities pharmaceutical companies have concerning social media activity in the recent release of a draft guidance document. As uncertainties still remain, the impact this guidance will have on pharmaceutical companies embracing this new venue of communication is unclear. The guidance gives pharmaceutical companies reassurance that they would not be held responsible for comments left by third parties on social media sites. But, as one expert points out, this should not be considered a reason to ignore the opportunities social media presents to engage with patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Clinical evidence in FDA drug approvals varies widely
Modern Healthcare
Not every new drug approved by the U.S. Food and Drug Administration has undergone the rigorous clinical testing that physicians and their patients might expect, according to new research. A study published in the Journal of the American Medical Association finds that the FDA has "flexible standards" for approving of new therapies.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    With genetic testing, patients can see the future (Star Tribune)
Estrogen promotes blood-forming stem cell function (Medical Xpress)
New contractor for insurance exchange website faces quite a challenge (By Pamela Lewis Dolan)
Google's Smart Contacts: Not the only groundbreaking medical tech (PC Magazine)

Don't be left behind. Click here to see what else you missed.


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
Jan. 30, 2014
Jan. 23, 2014
Jan. 16, 2014
Jan. 9 , 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063